cGAS-activating lupus autoantibody for cancer immunotherapy
Chen, X.; Tang, X.; Cuffari, B. J.; Tang, C.; Gao, X.; Noble, P. W.; Young, M. R.; Turk, O. M.; Shirali, A.; Gera, J.; Nishimura, R. N.; Zhou, J.; Hansen, J. E.
Show abstract
Cytoplasmic DNA triggers a cGAS-mediated signaling cascade that promotes an innate immune response and is potentially actionable in cancer immunotherapy. Here we show that a cytoplasmic-localizing lupus anti-DNA autoantibody activates cGAS and facilitates an immune-mediated prolongation of survival in orthotopic models of glioblastoma (GBM). Mechanistically, cellular penetration and blood-brain barrier crossing by the anti-DNA autoantibody is linked to nucleoside transport. Pulldown, knockdown, signaling, and cytotoxicity assays demonstrate autoantibody association with and activation of cGAS. In orthotopic GBM models, the autoantibody localizes to brain tumor, increases tumor CD8+ T cell content, and prolongs survival in immunocompetent but not immunodeficient mice. This work introduces the new concept of a cGAS-activating anti-DNA autoantibody, which impacts theories on mechanisms of autoimmunity and has translational applications in cancer immunotherapy.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High Affinity Chimeric Antigen Receptor with Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms 94%
- Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity 93%
- Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach. 93%
Similar papers in this journal
- Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy 94%
- Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation 94%
- The Cancer Testis Antigen Testis Specific Serine Kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors 93%
Similar papers in this journal
- The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer 93%
- Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma 93%
- Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy 93%
Similar papers in this journal
- Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma 94%
- PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma 93%
- Small Molecule Activators of B56-PP2A Restore 4E-BP Expression and Function to Suppress Cap-dependent Translation in Cancer Cells 93%
Similar papers in this journal
- ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells 93%
- MDR1 Drug Efflux Pump Promotes Intrinsic and Acquired Resistance to PROTACs in Cancer Cells 92%
- Reporter-based screening identifies RAS-RAF stabilizing mutations as drivers of resistance to broad-spectrum RAS inhibition in colorectal cancer 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.